Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

67870 Federal Register / Vol. 67, No.

216 / Thursday, November 7, 2002 / Notices

1002(a) authorizing the importation of DEPARTMENT OF JUSTICE Drug Schedule


such a substance, provide
manufacturers holding registrations for Drug Enforcement Administration Dextropropoxyphene, bulk (non- II
the bulk manufacture of the substance dosage forms) (9273).
an opportunity for a hearing. Manufacturer of Controlled Levo-Alphacetylmethadol (9648) .. II
Substances; Notice of Application Oxymorphone (9652) ................... II
Therefore, in accordance with Section Fentanyl (9801) ............................ II
1301.34 of Title 21, Code of Federal Pursuant to section 1301.33(a) of Title
Regulations (CFR), notice is hereby 21 of the Code of Federal Regulations
(CFR), this is notice that on May 21, The firm plans to manufacture small
given that on May 13, 2002, Chattem quantities of the listed controlled
Chemicals, Inc., 3801 St. Elmo Avenue, 2002, Aldrich Chemical Company Inc.,
dba Isotec, 3858 Benner Road, substances to produce standards for
Building 18, Chattanooga, Tennessee analytical laboratories.
37409, made application by renewal to Miamisburg, Ohio 45342–4304, made
application to the Drug Enforcement Any other such applicant and any
the Drug Enforcement Administration to
Administration (DEA) for registration as person who is presently registered with
be registered as an importer of
a bulk manufacturer of the basic classes DEA to manufacture such substances
methamphetamine (1105), a basic class
of controlled substances listed below: may file comments or objections to the
of controlled substance listed in issuance of the proposed registration.
Schedule II.
Drug Schedule Any such comments or objections
The firm plans to import the listed may be addressed, in quintuplicate, to
controlled substance to bulk Cathinone (1235) .......................... I
Methcathinone (1237) .................. I the Deputy Assistant Administrator,
manufacture controlled substance. Office of Diversion Control, Drug
N-Ethylamphetamine (1475) ........ I
Any manufacturer holding, or N,N-Dimethylamphetamine (1480) I Enforcement Administration, United
applying for, registration as a bulk Aminorex (1585) ........................... I States Department of Justice,
manufacturer of this basic class of Gamma hydroxybutyric acid I Washington, DC 20537, Attention: DEA
controlled substance may file written (2010). Federal Register Representative (CCR),
comments on or objections to the Methaqualone (2565) ................... I and must be filed no later than January
Lysergic acid dethylamide (7315) I 6, 2003.
application described above and may, at Tetrahydrocannabinols (7370) ..... I
the same time, file a written request for Mescaline (7381) .......................... I Dated: October 25, 2002.
a hearing on such application in 2,5-Dimethoxyamphetamine I Laura M. Nagel,
accordance with 21 CFR 1301.43 in (7396). Deputy Assistant Administrator, Office of
such form as prescribed by 21 CFR 3,4-Methylenedioxyamphetamine I Diversion Control, Drug Enforcement
1316.47. (7400). Administration.
3,4-Methylenedioxy-N- I
Any such comments, objections, or ethylamphetamine (7404). [FR Doc. 02–28314 Filed 11–6–02; 8:45 am]
requests for a hearing may be addressed, 3,4-Methylenedioxy-methamphet- I BILLING CODE 4410–09–M
in quintuplicate, to the Deputy Assistant amine (7405).
Administration, Office of Diversion 4-Methoxyamphetamine (7411) ... I
Control, Drug Enforcement Psilocybin (7437) .......................... I DEPARTMENT OF JUSTICE
Administration, United States Psilocyn (7438) ............................. I
Department of Justice, Washington, DC N-Ethyl-1-phenylcyclohexylamine I Drug Enforcement Administration
(7455).
20537, Attention: DEA Federal Register Dihydromorphine (9145) ............... I Manufacturer of Controlled
Representative (CCR), and must be filed Normorphine (9313) ..................... I Substances; Notice of Application
no later than (30 days from publication). Acetylmethadol (9601) ................. I
This procedure is to be conducted Alphacetylmethadol Except Levo- I Pursuant to section 1301.33(a) of Title
Alphacetylmethadol (9603). 21 of the Code of Federal Regulations
simultaneously with and independent
Normethadone (9635) .................. I
of the procedures described in 21 CFR (CFR), this is notice that on May 28,
3-Methylfentanyl (9813) ................ I
1301.34(b), (c), (d), (e), and (f). As noted Amphetamine (1100) .................... II 2002, Abbott Laboratories, DBA Knoll
in a previous notice at 40 FR 43745–46 Methamphetamine (1105) ............ II Pharmaceutical Company, 30 North
(September 23, 1975), all applicants for Methylphenidate (1724) ................ II Jefferson Road, Whippany, New Jersey,
registration to import basic class of any Amobarbital (2125) ....................... II 07981, made application by renewal to
controlled substance in Schedule I or II Pentobarbital (2270) ..................... II the Drug Enforcement Administration
are and will continue to be required to Secobarbital (2315) ...................... II (DEA) for registration as a bulk
1-Phenylcyclohexylamine (7460) II manufacturer of the basic classes of
demonstrate to the Deputy Assistant
Phencyclidine (7471) .................... II controlled substances listed below:
Administrator, Office of Diversion Phenylacetone (8501) .................. II
Control, Drug Enforcement 1-Piperidinocyclohexane- II
Administration that the requirements Drug Schedule
carbonitrile (8603).
for such registration pursuant to 21 Codeine (9050) ............................. II Dihydromorphine (9145) ............... I
U.S.C. 958(a), 21 U.S.C. 823(a), and 21 Dihydrocodeine (9120) ................. II Hydromorphone (9150) ................ II
CFR 1301.34(a), (b), (c), (d), (e), and (f) Oxycodone (9143) ........................ II
are satisfied. Hydromorphone (9150) ................ II
Benzoylecgonine (9180) ............... II The firm plans to produce bulk
Dated: October 25, 2002. Ethylmorphine (9190) ................... II product and finished dosage units for
Laura M. Nagel, Hydrocodone (9193) ..................... II distribution to its customers.
Isomethadone (9226) ................... II
Deputy Assistant Administrator, Office of
Meperidine (9230) ........................ II
Any other such applicant and any
Diversion Control, Drug Enforcement person who is presently registered with
Meperidine intermediate-A (9232) II
Administration. DEA to manufacture such substances
Merperidine intermediate-B (9233) II
[FR Doc. 02–28312 Filed 11–6–02; 8:45 am] Methadone (9250) ........................ II may file comments or objections to the
BILLING CODE 4410–09–M Methadone intermediate (9254) ... II issuance of the proposed registration.

VerDate 0ct<09>2002 14:39 Nov 06, 2002 Jkt 200001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\07NON1.SGM 07NON1

You might also like